Diversification must for Bangladesh: Lamy
Product and market diversification is a big challenge for Bangladesh, says the WTO chief who is now visiting Bangladesh on a two-day trip.
bdnews24.com News Service
bdnews24.com
Published :
31 Mar 2012, 01:06 PM
Updated :
09 Aug 2022, 03:36 PM
Dhaka, Mar 31 (bdnews24.com) – Product and location diversification is a big challenge for Bangladesh as it concentrates on single product and the US and the European Union for exports.
"Bangladesh's concentration is high on the US and the EU markets in view of not much trade with China, India or Thailand," WTO director general Pascal Lamy told the reporters after visiting Beximco Pharma factory at Tongi on Saturday.
The director general came to Dhaka on a two-day trip and attended the convocation programme at the Dhaka University in the morning.
About 75 per cent of the country's export earnings come from the readymade garment sector products destined to the European Union countries and the US.
When asked about the position of WTO on extending waiver under the Trade Related Intellectual Property Rights (TRIPS) for LDCs, he said it is for the members to decide and Bangladesh is also a member.
"The World Trade Organisation will review the waiver under TRIPs for the least developed countries at the end of 2013," he said.
He, however, said "...But that is not the problem (for Bangladesh). The real problem for Bangladesh is it may be graduated out of LDC status (before the waiver expiry period)," he added.
The country needs to increase its capacity to integrate itself with international system, Lamy added.
Bangladesh, being a least developed country, enjoys waivers under TRIPS which would expire on Dec 31, 2015.
About the operation of WTO, he said, there is a disagreement on the ninth version of the WTO rulebook.
"We have eight rulebooks and we are efficiently and properly managing the current one," he said adding, "China and the US have some disagreement with the ninth version."
"As the DG of this organisation, I never allocated even half the workforce for the development of the ninth version. Mostly they are busy with monitoring, technical assistance and other work," he added.
When asked about Beximco Pharma, he said, "This is a good demonstration of producing generic drugs for the poor of the country."
bdnews24.com/ssz/nir/1842h